Johnson & Johnson (JNJ) Cash from Financing Activities (2009 - 2026)

Johnson & Johnson has reported Cash from Financing Activities for 18 years, with the latest figure at -$8.8 billion in Q2 2026.

• Quarterly Cash from Financing Activities fell 54.93% year-over-year to -$8.8 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$18.5 billion (down 186.82% YoY) and the FY2025 annual result came in at -$5.5 billion, down 76.85% from the prior year.
• Cash from Financing Activities declined to -$8.8 billion in Q2 2026 per JNJ's latest filing, from $530.0 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $10.4 billion in Q1 2025 and troughed at -$11.3 billion in Q4 2023.
• A 5-year average of -$2.2 billion and a median of -$2.9 billion in 2022 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities tumbled 367.53% in 2023, then jumped 1808.79% in 2025.
• Over 5 years, Cash from Financing Activities stood at -$4.4 billion in 2022, then slipped by 6.16% to -$4.7 billion in 2023, then surged by 71.21% to -$1.3 billion in 2024, then decreased by 2.16% to -$1.4 billion in 2025, then plunged by 541.12% to -$8.8 billion in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$8.8 billion, $530.0 million, and -$1.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.